Optimizing Treatment Strategies for Metastatic NSCLC: Achieving the Best Patient Outcomes
home / meeting-of-the-minds / optimizing-treatment-strategies-for-metastatic-nsclc-achieving-the-best-patient-outcomes
The video series, Optimizing Treatment Strategies for Metastatic NSCLC: Achieving the Best Patient Outcomes, provides expert insights on patient selection, treatment sequencing, and managing adverse events to improve care for EGFR+ and ALK+ metastatic NSCLC patients.
EP. 1: Robert’s Journey With EGFR+ Metastatic NSCLC
December 23rd 2024Profiling a 58-year-old retired construction manager with Stage IV EGFR+ NSCLC, discussing his transition from osimertinib to amivantamab plus chemotherapy, managing side effects, and maintaining hope throughout his treatment journey.
